Drug Shortage Report for VITRAKVI
Report ID | 189904 |
Drug Identification Number | 02490315 |
Brand name | VITRAKVI |
Common or Proper name | LAROTRECTINIB |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | LAROTRECTINIB |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 56's |
ATC code | L01EX |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-04-24 |
Actual start date | 2023-04-25 |
Estimated end date | 2023-06-16 |
Actual end date | 2023-06-09 |
Shortage status | Resolved |
Updated date | 2023-06-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-06-10 | English | Compare |
v11 | 2023-06-09 | French | Compare |
v10 | 2023-06-09 | English | Compare |
v9 | 2023-06-08 | French | Compare |
v8 | 2023-06-08 | English | Compare |
v7 | 2023-05-23 | French | Compare |
v6 | 2023-05-23 | English | Compare |
v5 | 2023-04-28 | French | Compare |
v4 | 2023-04-28 | English | Compare |
v3 | 2023-04-25 | English | Compare |
v2 | 2023-04-20 | French | Compare |
v1 | 2023-04-20 | English | Compare |
Showing 1 to 12 of 12